Innogene

이노진 · 344860

Materials Chemicals · KOSDAQ

Small-cap

Market cap US$11.5M (₩15.8B)

Overview

Innogene makes cosmeceutical products, a category blending cosmetics with pharmaceutical-grade ingredients, focused on hair-loss relief and problem-skin care, including scalp treatments, home-care kits, scalp-care devices, health supplements, and pharmaceuticals.

It supplies clinics and hospitals across South Korea and exports to markets including the United States, China, Singapore, Hong Kong, and Malaysia. Listed on KOSDAQ, South Korea's tech and small-cap board, the company earns the large majority of its revenue from its hair-loss product line, with skin-beauty products making up the remainder.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$6M
▼ −8.2% YoY
Operating profit · FY2025
US$3.3K
▼ −99.3% YoY
Net income · FY2025
US$208.6K
▼ −69.5% YoY

Revenue

  • FY2023US$7.3M
  • FY2024US$6.5M
  • FY2025US$6M

Operating profit

  • FY2023US$888.7K
  • FY2024US$456.9K
  • FY2025US$3.3K

Net income

  • FY2023US$1M
  • FY2024US$684.9K
  • FY2025US$208.6K

Key ratios (FY2025)

ROE
2.0%
Debt/Eq
6.7%
Op. margin
0.1%
Net margin
3.5%
Rev. YoY
▼ −8.2%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.